Tony Goodman's Insider Trades & SAST Disclosures

Tony Goodman's most recent trade in Adial Pharmaceuticals Inc was a trade of 42,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 25, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Adial Pharmaceuticals Inc
Tony Goodman Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 42,000 42,000 - - Stock Option (Right to Buy)
Adial Pharmaceuticals Inc
Tony Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 50,000 50,000 - - Stock Option (Right to Buy)
Adial Pharmaceuticals Inc
Tony Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2022 25,000 25,000 - - Stock Option
Adial Pharmaceuticals Inc
Tony Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2022 40,000 40,000 - - Stock Option
Adial Pharmaceuticals Inc
Tony Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2021 40,000 40,000 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades